Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1447 | Pituitary Clinical | ICEECE2012

Acylated ghrelin as provocative test for the diagnosis of gh deficiency in adults

Gasco V. , Beccuti G. , Baldini C. , Prencipe N. , Guaraldi F. , Di Giacomo S. , Berton A. , Maccario M. , Ghigo E. , Grottoli S.

ITT is the test of reference for the diagnosis of adult GH deficiency (GHD), but also GHRH in combination with arginine (ARG) or GH secretagogues (GHS) are considered equally reliable tests. Testing with GHS alone is, anyway, a potent stimulus exploring the integrity of hypothalamic pathways controlling somatotropic function.We therefore aimed to clarify the diagnostic reliability of testing with ghrelin, the natural GHS.We studied...

ea0011p838 | Thyroid | ECE2006

Value of routine measurement of serum calcitonin concentrations in patients with nodular goiter: a multicenter study

Papi G , Corsello SM , Cioni K , Pizzini AM , Corrado S , Carapezzi C , Fadda G , Baldini A , Carani C , Pontecorvi A , Roti E

Context. The routine measurement of serum calcitonin (CT) has been proposed for patients with nodular goiter (NG), to detect unsuspected medullary thyroid carcinoma (MTC) before surgery. Objective To assess the prevalence of hypercalcitoninemia and MTC in NG patients; to compare the ability of CT measurement and fine needle aspiration cytology (FNAC) to predict MTC; to identify age groups of NG patients who should be better candidates than others to undergo routine measurement...

ea0092ps3-28-04 | Translational 2 | ETA2023

Effect of pazopanib in anaplastic thyroid cancer in primary culture

Martina Ferrari Silvia , Elia Giusy , Ragusa Francesca , Rosaria Paparo Sabrina , Mazzi Valeria , Patrizio Armando , Piaggi Simona , Baldini Enke , Centanni Marco , La Motta Concettina , Antonelli Alessandro , Fallahi Poupak

Anaplastic thyroid cancer (ATC) is usually treated with surgery, external hyperfractionated radiation therapy, and chemotherapy. However, because of the aggressiveness of this type of cancer, these treatments allow about 6-10 months of median survival. Therefore, it is challenging to predict the ATC patient clinical therapy responsiveness. Pazopanib is a multitarget tyrosine kinase inhibitor of VEGF receptors, PDGF, and c-Kit, and its effect in primary human ATC cells (pATC) h...

ea0037ep1036 | Thyroid (non-cancer) | ECE2015

Prevalence of hypothyroidism in a large series of adult thalassemic patients

Radin Raffaella , Danesi Leila , Ambrogio Alberto , Cassinerio Elena , Zanaboni Laura , Cappellini Maria Domenica , Baldini Marina , Poggi Maurizio , Ottaviani Chiara , Toscano Vincenzo , Zavattaro Marco , Cavagnini Francesco , Persani Luca , Scacchi Massimo

Hypothyroidism has been traditionally described as a frequent endocrine complication of thalassemic children: in these patients hypothyroidism is mainly of primary origin and not linked to autoimmunity (Mariotti et al., Pediatr Endocrinol Rev 2011). Fewer data are available on the prevalence and nature of this complication in adult age thalassemia. Therefore, we elected to evaluate thyroid function and autoimmunity in a large series of adult patients.<p class="abs...